The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...

Now, researchers have developed a new tool that could make painful biopsies a thing of the past—a small patch made of ...

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression, Cancer Cell, June 2025 DOI: (25)00253-3 ...

Non-invasive epithelial tumors of the ovary that show abnormal cell growth but lack the capacity to invade surrounding ...

An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, ...

At the INRS Armand-Frappier Santé Biotechnologie Research Centre , Professor Saleh's team is working to map the immune landscape of the brain in glioblastoma patients. Their research focuses on ...

We have been working on nanoneedles for twelve years, but this is our most exciting development yet. It opens a world of possibilities for people with brain cancer, Alzheimers, ...

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is classifying the clinical mass spectrometry microorganism identification and differentiation system into class II (special controls ...

At this week’s American Society for Mass Spectrometry (ASMS) Conference in Baltimore, Maryland, Sciex presented updates to its mass spectrometry product lineup, focusing on tools for quantitative ...

With the new Proteograph workflow, Seer achieves a transformative milestone by significantly improving the scalability, reproducibility, and affordability of deep proteomic analysis. These ...

The precursor analyte was detected with a ~78,000 FWHM mass resolution putatively identified as Acetaminophen Glucuronide with a 0.09 ppm mass accuracy (theoretical mass: 328.10269).